Purpose: The safety of chronic implantation of a retinal prosthesis in the suprachoroidal space has not been established. This study aimed to determine the safety of a wide-field suprachoroidal electrode array following chronic implantation using histopathological techniques and electroretinography.
Introduction
Degenerative retinal diseases are the leading cause of untreatable blindness. One of such diseases, retinitis pigmentosa (RP), has an estimated global prevalence of 1 in 3500 1 . Over the course of the disease process, the majority of the photoreceptors are lost, most commonly starting from the peripheral retina. Some ganglion and inner retinal cells survive, particularly in the center of the visual field 2 . Photoreceptor replacement by means of gene therapy and retinal transplantation has been clinically tested with moderate success in some disease conditions 3, 4 , but is not a clinical possibility yet and is not suitable for all retinal degenerative diseases.
Electrical stimulation of the visual pathway with a prosthetic device is a more promising alternative [5] [6] [7] .
An initial goal for a visual prosthetic device is to improve patient mobility and supplement the use of a guide dog or a long cane. Studies have shown that orientation and mobility are well correlated with the size of visual field and contrast sensitivity in RP 8 , with nearly 70% of the variance in walking speed being accounted for by these two measures 9 . A retinal prosthesis providing a wide visual field (e.g. larger than 20˚) could be effective at improving mobility 10 , while achieving high resolution would potentially allow reading and face recognition 11 . There are several viable targets in the visual pathway for a prosthetic device; stimulation of the visual cortex 12, 13 or the optic nerve 14, 15 are potential alternatives, but stimulation at the retinal level provides simpler surgical access, a simple retinotopic map of the visual field and utilizes more of the existing neuronal processing. This prosthesis would need to cover a considerable area of the retina to produce wide field perception.
Several anatomical locations for electrical stimulation of the neural retina are being investigated, including epiretinal, subretinal and suprachoroidal sites. Epiretinal implants have shown promise during clinical trials in long 16, 17 and short term implantation [18] [19] [20] as well as acute testing 21, 22 .
Implanted patients have shown significant improvement in detecting and counting objects and form discrimination tasks 16 . Epiretinal implantation can be safe 23 but carries the risks of surgical trauma, poor implant fixation 24 , retinal reorganization due to uneven pressure from the implant 25 and retinal detachment 26 . Subretinal implants have been well tolerated in clinical trials 27 and some implanted patients have been able to recognize objects and read letters 28 . Subretinal implantation can provide stable mechanical fixation but has greater degree of surgical difficulty and there is a limit to the size of the implant and prospective visual field 29 . The risks associated with subretinal implantation include loss of the residual photoreceptor layer [30] [31] [32] [33] , reorganization of the inner retina 33 , disruption of the retinal pigment epithelium 34 and surgical trauma including retinal perforations 35 . Intrascleral electrodes have been successful in eliciting percepts in blind patients in semi-chronic 36 and acute testing 37 . Suprachoroidal and intrascleral implantation for transchoroidal stimulation are safer and less demanding surgical approaches but carry the risk of bleeding 38 and retinal damage at pressure points related to implant design 39, 40 . These transchoroidal stimulation sites come at the cost of higher thresholds compared with optimally placed epi-or subretinal electrode arrays 41 . However, spatially selective excitation of the neuroretina has been shown using suprachoroidal electrodes and stimulation levels well within the safe limits for platinum electrodes 42 .
A suprachoroidal retinal prosthesis is a promising alternative for a large visual field electrode array. Suprachoroidal implants have been shown to be well tolerated by the eye 43 with minimal risk of damage to the neural retina 41, 44 . The implantable electrode array needs to be designed for ease of surgical implantation, have spherical conformability 45 and robust scleral closure 40 . In this study, a wide, conformable electrode array designed for the suprachoroidal space, with a transscleral lead, was evaluated for its long-term safety following chronic implantation in normally sighted cats.
Materials and Methods
The procedures for this study were approved by the 
Suprachoroidal electrode array
An array of 21 platinum (Pt) electrodes (⌀ 600 µm, 99.95% Pt; Goodfellow, Cambridge, England) was fabricated in a 19 mm × 8 mm silicone substrate as shown in Figure 1 . There were also 2 Pt return electrodes (⌀ 2 mm). The substrate was tapered radially from 1 mm to a thickness of 150 µm near the edges and then slanted to a minimum thickness; this was done to improve spherical conformability and facilitate insertion 47 . 49 , and then maintained with a continuous flow of isoflurane (Delvet, Australia) in oxygen through an endotracheal tube for the remainder of the procedure.
The basic implantation procedure, which was developed in a previous study 40 , was refined and adapted to ensure strong scleral closure for chronic implantation. The surgical steps used are summarized in Figure 2 . First, a lateral canthotomy was performed, followed by a temporal 180˚ conjunctival peritomy. Bipolar diathermy was applied to the sclera at the temporal quadrant. A 9 mm long, full-thickness scleral incision was performed 5 mm posterior and parallel to the limbus. Immediately postoperatively the eye was visually assessed for hemorrhage, retinal detachment and electrode array location, using an indirect ophthalmoscope. This assessment was repeated daily for 7 days, then at 2 weeks and then again at 3 months.
Postoperative care
After surgery, the cats were administered buprenophrine (0.01 mg/kg, s.c; Temgesic; Reckitt Benckiser, Australia) for analgesia when the anesthetic was withdrawn. For the first week the animal was given amoxicillin-clavulanate suspension once daily (10mg/kg, s.c; Clavulox; Pfizer, Italy). Topical drugs were administered twice daily for the first 14 days and tapered off as required, these included prednisolone (Prednefrin Forte; Allergan, Australia), atropine (Atropt;
Sigma Pharmaceuticals, Australia) and chloramphenicol (Chlorsig; Sigma Pharmaceuticals).
The drops were given until edema had resolved. All animals were checked daily for general health. Two weeks after surgery, the animals were anesthetized with ketamine-xylazine (1 and 10 mg/kg respectively, s.c.) and sutures were removed. The animals were monitored during 3 months for general health and the implanted eye was assessed visually for surgical recovery or signs of irritation.
Electroretinography assessment
An ERG was performed at 2 weeks and 3 months after implantation. Pupils were dilated with tropicamide 1% (Mydriacyl; Alcon Laboratories, Australia). The ERG was recorded using corneal contact lens electrodes (ERG-Jet; Fabrinal SA, Switzerland) on both eyes simultaneously. Flash stimuli were delivered by a Ganzfeld stimulator (ColorDome; Diagnosys LLC, Lowell, MA). An electrophysiology system (Espion E2; Diagnosys LLC) was used for stimulus generation and data acquisition. After a dark-adaptation period of 20 minutes, the ERG was recorded over a range of flash intensities (-4.0 to 1.0 log cd/m 2 in 0.3 log unit increments).
Termination and histological methods
After three months of implantation, the animals were anesthetized for an electrophysiologic experiment lasting two days. The electrodes were stimulated within an arbitrary charge density .
Following a macroscopic pathology assessment for anterior chamber hyphema or fibrosis, lens or vitreous opacity and noticeable retinal damage; the eyes were prepared for histological processing. The extraocular tissue surrounding the lead was first separated from the eye. The electrode array was then removed from the eye by dissecting on the original scleral wound site and carefully extracting the device. The sclera was dyed with markings at 4 mm spacing from the optic nerve following the horizontal meridian ( Figure 3A ). The eyes were dissected and three or more narrow (2 mm) strips were cut from the implanted region at strategic locations ( Figure   3B ,C). The strips were taken from the following sites: 1) transversal horizontal section including implant tip region, optic disc and nasal region; 2) sagittal strip through a cross section of the implant tract, 8 mm from the optic nerve; 3) temporal transversal section including the anterior implanted region and original insertion site; 4) section from the extraocular proliferative tissue surrounding the episcleral patch; 5) section from the extraocular tissue surrounding the cable lead. In some cases, where the electrode was positioned obliquely, an additional section (parallel to section 1) was collected to include the implant tip region. Tissue strips were embedded in agar to reduce delamination artifacts 54 . Samples, supported by foam inserts, were transferred into 10% NBF for 1-3 h before processing in a standard automated cycle. Sections were stained with hematoxylin and eosin (H&E) using a standard automated process. Other special stains were processed manually using standard histological procedures.
Histopathological assessment
The stained histological slides were inspected to find one slide per site and per eye with consistent staining and completeness of section. The selected slide was assessed based on the following criteria: implant location, retinal damage, active inflammatory response, chronic inflammatory response, fibrosis, hemorrhage and other pathological changes. Degrees of retinal damage, fibrosis and inflammatory reaction were scored on a 4 level scale (none, mild, moderate and severe). Hemorrhage and retinal detachment were quantified as present or absent.
Statistical analyses
The unoperated right eyes were used as controls. 
Results

Postoperative observations
In all seven cases, the implant was reliably positioned in the suprachoroidal space without breaching the retina, similar to the results from acute implantation studies using a thin film electrode array 40 . The summary of surgical complications in Table 1 shows that there were no major postoperative complications such as hyphema, vitreous hemorrhage or retinal detachment. Fundus examination showed that an initial elevation of the retina over the implanted region, likely associated with edema, resolved within 2 weeks. This is consistent with previous studies of suprachoroidal implantation 55 . At 3 months postoperative, the implant tract could only be distinguished as a contrast change against the bright tapetum on color fundus photographs ( Figure 4 ). There were no cases of staphyloma or choroidal incarceration.
A small subretinal hematoma developed in all eyes within 2 weeks postoperatively. These regions were typically 1-2 optic disc diameters in size. They were visible as a dark pigmentary changes contrasting with the reflective tapetum tissue as shown with a star in Figure 4 . Only in 3 eyes were these visible intraoperatively. The hematomas developed within the first 2-3 days and then stabilized. One animal developed overt subretinal hemorrhage. This was observed as an extended elevation of the retina over the superior quadrant. The edema resolved before 7
weeks and the retina reattached leaving thin strips of pigmentary changes in the tissue.
The implants were mechanically stable during 3 months of implantation. Figure 5 shows the location of the implant outline at three different time points. Implants 03, 05 and 06 suffered an initial displacement of about 1-3 optic disc diameters within the first two weeks. The movement appeared to be rotational around the fixation point at the transscleral exit. The implants then remained stable through to the completion of the experiment.
Electroretinography
The ERG b-wave amplitude of the implanted and control eyes at 2 weeks and 3 months postimplantation are shown in Figure 6 . There was a significant increase in the b-wave amplitude of the combined rod-cone bright flash ERG (1.0 log cd/m 2 ) in the implanted eyes compared to the control eyes at 2 weeks post-implantation (paired t-test, P < 0.01). This enhancement of the ERG response was temporary and returned to the normal amplitude level at 3 months postimplantation.
Histopathology
Analysis of the different tissue sampling sites showed more pronounced tissue reaction in the extraocular sections (4, 5 in Figure 3C ) when compared to the intraocular sections (1, 2, 3 in Figure 3B ). The median score for each pathological category, as shown in Figure 7 , was different for the internal tissue sections taken from the eye and the tissue sections taken from the orbital lead region (Mood's median test P < 0.001 for active, chronic inflammation and fibrosis). Analyses were separated into the intraocular implant tract region and the extraocular lead region as described below.
Intraocular pathologies
The pathological scoring, as presented in Table 2 , showed that intraocular pathologies had low incidence or low severity (95% CI for the median of none to mild). The typical response in all eyes was a thin layer of tissue consisting of fibroblasts and occasional macrophages or foreign body giant cells. The tissue response on the surface of the implant was 1 or 2 cells thick as shown in Figure 8G . On the scleral side of the implant the tissue response was more varied, with scattered foci of chronic inflammatory cells. A mild to moderate fibrotic layer was observed around the implant in 5 of 7 cases. At the edges of the array the inflammation was more pronounced than on the flat surfaces of the implant ( Figure 8F,I ), but not significantly more active. The implant edges were well tolerated and did not create scleral deformations nor retinal detachment.
In the eye which developed subretinal hemorrhage after implantation (animal 04), there was a moderate reaction with a thicker fibrous layer, mild ongoing active inflammation and localized foci of outer retinal disruption with proliferation of retinal pigment epithelial (RPE) cells. These spots of retinal disruption were less than 300 µm wide (one is shown in Figure 9A ) and they were scattered across the superior retina, where hemorrhage was observed during in vivo assessments. The retina was normal otherwise. In all seven cases, the retina adjacent to the electrode array appeared normal.
A mild active inflammatory reaction (scattered neutrophils) was found near the scleral incision in 6 of 7 eyes. This was accompanied by an increased chronic inflammatory response. Figure 8C shows an example of histiocytic reaction (moderate) in this region. The inflammatory reaction was significantly higher near the scleral incision than in the rest of the implant cavity (Mood's median test P < 0.01 for active and chronic inflammation, excluding animal 04 due to overt hemorrhage).
Pigmentary changes were observed macroscopically near the distal tip of the implant, as shown in Figure 4 . Histological examination of these areas revealed disorganization in the choroidal melanin: pigment particles had been disrupted by the inflammatory reaction and absorbed by macrophages. An example is shown in Figure 9C . In 2 of 7 eyes there was also associated localized retinal damage. In animal 03 there was a 1.5 mm region of retinal degeneration ( Figure 9B ) near the implant tip and in animal 05 the retinal disruption was 200 µm wide.
In animal 07, the anterior edge of the implant body extruded through the sclera but remained under the conjunctiva. The anterior scleral tissue became contiguous with the foreign body response at the choroidal side of the implant tract, as shown in Figure 9D . Conjunctival epithelial down-growth was found extending into the implant tract as can be seen in Figure 9E .
Examination of the implants post-explantation revealed that the leads had different angles at rest with respect to the implant body plane. The lead in the implant that extruded rested at an angle of 27˚ whereas in the rest of the implants the angle was in the range of 0 ̶ 13˚.
Extraocular pathologies
The response to the lead in the extraocular orbital region was more significant. A thick layer of fibrotic tissue developed around the lead and the fixation patches. This tissue was sectioned and processed as described above. Histological examination of the episcleral patch region (4 in Figure 3C ) revealed that, typically, there was a dense fibrosis and granulation tissue. There were moderate numbers of neutrophils.
The reaction surrounding the lead region (5 in Figure 3C ) consisted of a thicker fibrotic layer and granulation tissue plugs. Figure 10 shows an example of the tissue encapsulation around the lead with thick fibrotic tissue as a result of movement. . The variability of the inflammatory response found in the intraocular implant tract is not a major concern for the viability of the neural prosthesis 59 . The thin edges of the electrode array, which have been a site of concern in retinal prostheses 60 , did not show a significantly greater tissue response and were well tolerated.
The retina was generally intact and functional over the implanted region. Amplitudes of the ERG showed normal retinal function after 3 months of implantation in all cats, when compared with their fellow control eye. There was increased ERG amplitude in the implanted eyes at 2 weeks postoperative. The increase in ERG amplitude after suprachoroidal implantation has been reported previously 41 and was not found to be associated with retinal damage, whereas in that same study subretinal implantation decreased the ERG amplitude in association with photoreceptor loss. Multi-focal ERG could be used in future studies to investigate the localized functional changes at the implantation site. From the histology, focal disruptions of the outer retinal structure were only found near the inferonasal corner of the electrode array (the one closest to the optic nerve), except for animal 04 which suffered extended suprachoroidal hemorrhage and had distributed disruption foci across the retina. These distributed foci of retinal disruption, consisted of proliferation of RPE cells or photoreceptor "rosette" formation, which have been reported previously with subretinal implantation 33, 34 . This retinal dysplasia could be associated with a temporary elevation of the retina. Overall, the retina of this animal was well preserved and showed no loss of function.
The region of hyperpigmentation and occasional outer retinal disruption, near the inferonasal corner of the electrode array, was similar to the retinal disruption found in a previous study which was caused by the implant being close to the optic disc 40 . That previous publication indicated that a thin film electrode array should not be implanted closer than 2.6 mm to the optic disc in cats; it would be expected that the retinal disruption observed in the present study could be avoided by increasing the clearance from the optic disc. The retinal disruption was consistently located near the insertion point of the short posterior ciliary arteries and posterior ciliary veins in the cat 50 . The pigment disruption region could have resulted from a minor disturbance of the ciliary vessels with the implant edge. This would explain the slow evolution of the pigmented region over the course of 2-3 days and one case of extensive suprachoroidal hemorrhage. It is known that bleeding behind the RPE appears dark and round with fundoscopic examination 61 . Localized hyperpigmentation in cat and dog retinas has been reported in retinal prosthesis studies with epiretinal, subretinal, suprachoroidal and intrascleral implantation 30, 33, 39, [62] [63] [64] . In those studies, hyperpigmentation was associated with focal tissue disruption and it did not compromise the integrity of the inner retina for electrical stimulation. These issues could be investigated further in vivo using optical coherence tomography, which was not available during this study. ; disruption due to contact or pressure 25, 70 ; plus the unsecure fixation may cause the implant to move 24 or become detached 16 . These risks appear to be related to the shape and mechanical properties of the device, in which case a wider field device would likely increase their incidence. Implanting multiple devices in an eye remains an unexplored avenue for extending the visual field.
This study features the surgical implantation of a wide-field device into a suprachoroidal cleavage plane, created by advancing the device against the inner surface of the sclera which provides mechanical support. Consequently, manipulation of the reorganized retina 71 and thinned choroid 72 in RP patients would be minimized. The wide-field implant substrate with 21 electrodes at the distal tip was tolerated in the cat suprachoroidal space. The visual field covered by the array could be extended with more electrodes to cover the full 19 mm × 8 mm area of the substrate. On the other hand, the visual acuity achievable in a clinical setting would depend not only on the number of electrodes but also on other factors including: distance to the retina, pathophysiological status of the retina, stimulation-dependent shunting of currents 42 and stimulation strategies 73, 74 . Covering a wide visual field and minimizing damage to the retina are the initial goals.
In the present study, the tissue reaction over the anterior end of the implant, at the scleral incision site, was moderate. This could have spread from the more severe extraocular tissue reaction. It is also likely that the movement from the extraocular lead during fixation saccades was transferred to the implant substrate. As a result, the mechanical stress could have caused the increased inflammation observed at this site. In the single case where the implant extruded out of the sclera, the cable lead was defective with a high angle against the implant body. Here, the force from cable fixation was likely to produce constant outward pressure from the implant body on the sclera, which is known to be relatively acellular and avascular 75 and already weakened by the application of diathermy. Slow erosion through the sclera under constant tension of an implant has been shown before 76 . The reaction caused by this anterior part of the implant would be improved by designing the lead and scleral patch to minimize mechanical forces on the implant body.
Outside the eye, there was a thick capsule of proliferative tissue surrounding the lead. The granulation tissue with ongoing active inflammation indicates the presence of continued irritation, probably due to movement. This is likely to develop into a thick fibrous capsule 58 , where the ongoing irritation is contained and isolated from the rest of the tissue. The inflammatory reaction observed at 3 months was probably not fully resolved and may take longer to evolve into a mature tissue response.
The foreign body reaction associated with the large electrode array was mild, indicating it was mechanically stable and biocompatible. Mild pigmentary disruption and occasional focal damage to the outer retina occurred at the inferonasal corner of the implant substrate. The retina over the electrodes remained largely intact in all cases. It has been shown previously from animal studies that suprachoroidal implantation results in no obvious damage to the eye structures 38, 44, 55 . The main risks found were suprachoroidal bleeding by disruption of the vessels, which occurred in 1 of 7 cats, and implant extrusion through the sclera. Improved 
